NTRK Fusions in a Sarcomas Series: Pathology, Molecular and Clinical Aspects

Targeting molecular alterations has been proven to be an inflecting point in tumor treatment. Especially in recent years, inhibitors that target the tyrosine receptor kinase show excellent response rates and durable effects in all kind of tumors that harbor fusions of one of the three neurotrophic t...

Descripción completa

Detalles Bibliográficos
Autores principales: Siozopoulou, Vasiliki, Marcq, Elly, De Winne, Koen, Norga, Koen, Schmitz, Gertjan, Duwel, Valerie, Delvenne, Philippe, Smits, Evelien, Pauwels, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130470/
https://www.ncbi.nlm.nih.gov/pubmed/35645621
http://dx.doi.org/10.3389/pore.2022.1610423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130470/
https://www.ncbi.nlm.nih.gov/pubmed/35645621
http://dx.doi.org/10.3389/pore.2022.1610423

Ejemplares similares